Fiscal Year:
2010
Title:
Low-Dose MRI-Compatible Molecular Breast Imaging Device
Agency:
HHS
Contract:
1R43CA144079-01
Award Amount:
$385,853.00
Abstract:
DESCRIPTION (provided by applicant): Molecular breast imaging with tumor-seeking radiotracers has been shown to be highly accurate in the detection of breast cancer, particularly for pre-invasive lesion. Removal of pre-invasive lesions represents an ideal
target for invasive cancer prevention. In order to conduct cancer prevention studies, we must significantly reduce the radiation dose associated with molecular breast imaging and implement MRI compatibility, without sacrificing spatial and energy resolutio
n. MRI compatibility with co-registration would likely increase sensitivity for detecting small invasive cancers and improve overall diagnostic accuracy. PUBLIC HEALTH RELEVANCE: Use of our proposed system will yield economic benefits that result fr
om detection (and treatment) of pre-invasive breast cancers, so as to avoid the more expensive treatment of patients with potentially metastatic invasive breast cancer. Prevention of invasive breast cancer is expected to prolong life and reduce anxiety for
a large number of high-risk women.
Small Business Information at Submission:
WEINBERG MEDICAL PHYSICS, LLC
WEINBERG MEDICAL PHYSICS LLC 5611 ROOSEVELT ST BETHESDA, MD 20817
EIN/Tax ID:
126201519
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned:
No
Minority-Owned:
No
HUBZone-Owned:
No